Loading...
XNAS
TCMD
Market cap692mUSD
Jul 09, Last price  
30.68USD
1D
2.33%
1Q
30.94%
Jan 2017
86.96%
IPO
172.47%
Name

Tactile Systems Technology Inc

Chart & Performance

D1W1MN
XNAS:TCMD chart
P/E
36.26
P/S
2.10
EPS
0.85
Div Yield, %
Shrs. gr., 5y
3.78%
Rev. gr., 5y
11.98%
Revenues
330m
+12.47%
37,176,00047,736,00062,872,00084,542,000109,283,000143,751,000189,492,000187,130,000208,057,000246,785,000274,423,000292,984,000329,522,000
Net income
19m
+12.54%
3,156,0002,070,0001,393,0002,879,0005,855,0006,623,00010,971,000-620,000-11,811,000-17,866,00028,515,00016,960,00019,086,000
CFO
43m
+5.30%
-11,811,000-425,000-991,0001,358,0007,033,0004,192,0009,007,0002,510,0002,794,0002,631,0005,209,00035,855,00040,655,00042,811,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Tactile Systems Technology, Inc. is a medical technology firm that develops and supplies specialized devices to treat chronic health conditions across the United States. Its product portfolio features the Flexitouch Plus system, a pneumatic compression device designed for managing lymphedema. The company also offers the Entre system, a portable pneumatic compression solution for at-home treatment of various venous disorders, including lymphedema, chronic venous insufficiency, and venous leg ulcers. Additionally, Tactile Systems provides the AffloVest, a portable high-frequency chest wall oscillation device used to address retained pulmonary secretions associated with conditions such as bronchiectasis, cystic fibrosis, and certain neuromuscular disorders. Established in 1995, the company maintains its headquarters in Minneapolis, Minnesota.
IPO date
Jul 28, 2016
Employees
982
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT